Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease

Published on 2020-10-012023-06-20
Journal: Gastroenterology

[저자] Dana J Lukin, Anand Kumar, Kaveh Hajifathalian, Reem Z Sharaiha, Ellen J Scherl, Randy S Longman, Jill Roberts Center Study Group Study Group, Weill Cornell Medicine-Gastrointestinal Study Group

[Category] Fulltext, MERS,

PMC URL Pubmed URL [DOI] 10.1053/j.gastro.2020.05.066

[Source] pubmed

All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, IBD, Biologic therapy,